205 related articles for article (PubMed ID: 35464443)
1. Comprehensive Oncogenic Features of Coronavirus Receptors in Glioblastoma Multiforme.
Chen A; Zhao W; Li X; Sun G; Ma Z; Peng L; Shi Z; Li X; Yan J
Front Immunol; 2022; 13():840785. PubMed ID: 35464443
[TBL] [Abstract][Full Text] [Related]
2. Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses.
Qi F; Qian S; Zhang S; Zhang Z
Biochem Biophys Res Commun; 2020 May; 526(1):135-140. PubMed ID: 32199615
[TBL] [Abstract][Full Text] [Related]
3. Evidence for residual SARS-CoV-2 in glioblastoma tissue of a convalescent patient.
Lei J; Liu Y; Xie T; Yao G; Wang G; Diao B; Song J
Neuroreport; 2021 Jun; 32(9):771-775. PubMed ID: 33994523
[TBL] [Abstract][Full Text] [Related]
4. Renal Carcinoma Is Associated With Increased Risk of Coronavirus Infections.
Tripathi SC; Deshmukh V; Creighton CJ; Patil A
Front Mol Biosci; 2020; 7():579422. PubMed ID: 33330620
[No Abstract] [Full Text] [Related]
5. Expression of the COVID-19 receptor ACE2 in the human conjunctiva.
Lange C; Wolf J; Auw-Haedrich C; Schlecht A; Boneva S; Lapp T; Horres R; Agostini H; Martin G; Reinhard T; Schlunck G
J Med Virol; 2020 Oct; 92(10):2081-2086. PubMed ID: 32374427
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive analysis of two potential novel SARS-CoV-2 entries, TMPRSS2 and IFITM3, in healthy individuals and cancer patients.
Dai YJ; Zhang WN; Wang WD; He SY; Liang CC; Wang DW
Int J Biol Sci; 2020; 16(15):3028-3036. PubMed ID: 33061814
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin-converting enzyme 2, coronavirus disease 2019, and abdominal aortic aneurysms.
Xu B; Li G; Guo J; Ikezoe T; Kasirajan K; Zhao S; Dalman RL
J Vasc Surg; 2021 Nov; 74(5):1740-1751. PubMed ID: 33600934
[TBL] [Abstract][Full Text] [Related]
8. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
9. Age and gender differences in ACE2 and TMPRSS2 expressions in oral epithelial cells.
Peng J; Sun J; Zhao J; Deng X; Guo F; Chen L
J Transl Med; 2021 Aug; 19(1):358. PubMed ID: 34412632
[TBL] [Abstract][Full Text] [Related]
10. A bioinformatics analysis on the potential role of ACE2 in cardiac impairment of patients with coronavirus disease 2019.
Wang W; Lv S; Gan W; Zeng Z; Yang M
Ann Transl Med; 2020 Nov; 8(21):1403. PubMed ID: 33313148
[TBL] [Abstract][Full Text] [Related]
11. Spironolactone may provide protection from SARS-CoV-2: Targeting androgens, angiotensin converting enzyme 2 (ACE2), and renin-angiotensin-aldosterone system (RAAS).
Cadegiani FA; Goren A; Wambier CG
Med Hypotheses; 2020 Oct; 143():110112. PubMed ID: 32721806
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19).
Bourgonje AR; Abdulle AE; Timens W; Hillebrands JL; Navis GJ; Gordijn SJ; Bolling MC; Dijkstra G; Voors AA; Osterhaus AD; van der Voort PH; Mulder DJ; van Goor H
J Pathol; 2020 Jul; 251(3):228-248. PubMed ID: 32418199
[TBL] [Abstract][Full Text] [Related]
13. Searching therapeutic strategy of new coronavirus pneumonia from angiotensin-converting enzyme 2: the target of COVID-19 and SARS-CoV.
Li SR; Tang ZJ; Li ZH; Liu X
Eur J Clin Microbiol Infect Dis; 2020 Jun; 39(6):1021-1026. PubMed ID: 32285293
[TBL] [Abstract][Full Text] [Related]
14. ACE2, TMPRSS2 distribution and extrapulmonary organ injury in patients with COVID-19.
Dong M; Zhang J; Ma X; Tan J; Chen L; Liu S; Xin Y; Zhuang L
Biomed Pharmacother; 2020 Nov; 131():110678. PubMed ID: 32861070
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms and mutations of ACE2 and TMPRSS2 genes are associated with COVID-19: a systematic review.
Li J; Wang Y; Liu Y; Zhang Z; Zhai Y; Dai Y; Wu Z; Nie X; Du L
Eur J Med Res; 2022 Feb; 27(1):26. PubMed ID: 35193695
[TBL] [Abstract][Full Text] [Related]
16. Immune Interaction Map of Human SARS-CoV-2 Target Genes: Implications for Therapeutic Avenues.
Subbarayan K; Ulagappan K; Wickenhauser C; Bachmann M; Seliger B
Front Immunol; 2021; 12():597399. PubMed ID: 33796097
[TBL] [Abstract][Full Text] [Related]
17. Protein structure analysis of the interactions between SARS-CoV-2 spike protein and the human ACE2 receptor: from conformational changes to novel neutralizing antibodies.
Mercurio I; Tragni V; Busto F; De Grassi A; Pierri CL
Cell Mol Life Sci; 2021 Feb; 78(4):1501-1522. PubMed ID: 32623480
[TBL] [Abstract][Full Text] [Related]
18. The pivotal link between ACE2 deficiency and SARS-CoV-2 infection.
Verdecchia P; Cavallini C; Spanevello A; Angeli F
Eur J Intern Med; 2020 Jun; 76():14-20. PubMed ID: 32336612
[TBL] [Abstract][Full Text] [Related]
19. Simian Immunodeficiency Virus Infection Mediated Changes in Jejunum and Peripheral SARS-CoV-2 Receptor ACE2 and Associated Proteins or Genes in Rhesus Macaques.
Boby N; Cao X; Williams K; Gadila SKG; Shroyer MN; Didier PJ; Srivastav SK; Das A; Baker K; Sha Q; Pahar B
Front Immunol; 2022; 13():835686. PubMed ID: 35281029
[TBL] [Abstract][Full Text] [Related]
20. Single-cell transcriptome analysis of the novel coronavirus (SARS-CoV-2) associated gene ACE2 expression in normal and non-obstructive azoospermia (NOA) human male testes.
Liu X; Chen Y; Tang W; Zhang L; Chen W; Yan Z; Yuan P; Yang M; Kong S; Yan L; Qiao J
Sci China Life Sci; 2020 Jul; 63(7):1006-1015. PubMed ID: 32361911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
